Literature DB >> 19106674

Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized control trial: short-term results of the Sigma Trial.

Bastiaan R Klarenbeek1, Alexander A Veenhof, Roberto Bergamaschi, Donald L van der Peet, Wim T van den Broek, Elly S de Lange, Willem A Bemelman, Piet Heres, Antonio M Lacy, Alexander F Engel, Miguel A Cuesta.   

Abstract

BACKGROUND: No randomized controlled trial has compared laparoscopic sigmoid resection (LSR) to open sigmoid resection (OSR) for symptomatic diverticulitis of the sigmoid colon. This study tested the hypothesis that LSR is associated with decreased postoperative complication rates as compared with OSR.
METHODS: This was a prospective, multicenter, double-blind, parallel-arm, randomized controlled trial. Eligible patients were randomized to either LSR or OSR. Endpoints included postoperative mortality, and complications were classified as major and minor. The generator of the allocation sequence was separated from the executor. Blinding was ensured using an opaque wound dressing to cover the abdomen. Symptomatic diverticulitis of the sigmoid colon was defined as recurrent disease Hinchey I, IIa, IIb, symptomatic stricture, or severe rectal bleeding. The decision to discharge patients was made by independent physicians blind to the allocation sequence. Data were analyzed according to the intention to treat principle.
RESULTS: From 2002 to 2006, 104 patients were randomized in 5 centers. All patients underwent the allocated intervention. Fifty-two LSR patients were comparable to 52 OSR patients for gender, age, BMI, ASA grade, comorbid conditions, previous abdominal surgery, and indication for surgery. LSR took longer (P = 0.0001) but caused less blood loss (P = 0.033). Conversion rate was 19.2%. Mortality rate was 1%. There were significantly more major complications in OSR patients (9.6% vs. 25.0%; P = 0.038). Minor complication rates were similar (LSR 36.5% vs. OSR 38.5%; P = 0.839). LSR patients had less pain (Visual Analog Scale 1.6; P = 0.0003), systemic analgesia requirement (P = 0.029), and returned home earlier (P = 0.046). The short form-36 questionnaire showed significantly better quality of life for LSR.
CONCLUSIONS: LSR was associated with a 15.4% reduction in major complication rates, less pain, improved quality of life, and shorter hospitalization at the cost of a longer operating time.

Entities:  

Mesh:

Year:  2009        PMID: 19106674     DOI: 10.1097/SLA.0b013e31818e416a

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  101 in total

1.  Surgical treatment of acute recurrent diverticulitis: early elective or late elective surgery. An analysis of 237 patients.

Authors:  Henry Hoffmann; Salome Dell-Kuster; Jörg Genstorfer; Christoph Kettelhack; Igor Langer; Rachel Rosenthal; Daniel Oertli; Oleg Heizmann
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

2.  Laparoscopic approach to acute abdomen from the Consensus Development Conference of the Società Italiana di Chirurgia Endoscopica e nuove tecnologie (SICE), Associazione Chirurghi Ospedalieri Italiani (ACOI), Società Italiana di Chirurgia (SIC), Società Italiana di Chirurgia d'Urgenza e del Trauma (SICUT), Società Italiana di Chirurgia nell'Ospedalità Privata (SICOP), and the European Association for Endoscopic Surgery (EAES).

Authors:  Ferdinando Agresta; Luca Ansaloni; Gian Luca Baiocchi; Carlo Bergamini; Fabio Cesare Campanile; Michele Carlucci; Giafranco Cocorullo; Alessio Corradi; Boris Franzato; Massimo Lupo; Vincenzo Mandalà; Antonino Mirabella; Graziano Pernazza; Micaela Piccoli; Carlo Staudacher; Nereo Vettoretto; Mauro Zago; Emanuele Lettieri; Anna Levati; Domenico Pietrini; Mariano Scaglione; Salvatore De Masi; Giuseppe De Placido; Marsilio Francucci; Monica Rasi; Abe Fingerhut; Selman Uranüs; Silvio Garattini
Journal:  Surg Endosc       Date:  2012-06-27       Impact factor: 4.584

Review 3.  Elective open versus laparoscopic sigmoid colectomy for diverticular disease: a meta-analysis with the Sigma trial.

Authors:  Muhammed R S Siddiqui; Muhammed S Sajid; Kamran Khatri; Elizabeth Cheek; Mirza K Baig
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

4.  Laparoscopic management of diverticular disease.

Authors:  Jeremy M Lipman; Harry L Reynolds
Journal:  Clin Colon Rectal Surg       Date:  2009-08

Review 5.  Quality of life after laparoscopic and open colorectal surgery: a systematic review.

Authors:  Sanne A L Bartels; Malaika S Vlug; Dirk T Ubbink; Willem A Bemelman
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

6.  How complicated is complicated diverticulitis?--phlegmonous diverticulitis revisited.

Authors:  Christian F Jurowich; Stefanie Jellouschek; Ralf Adamus; Reinhard Loose; Annette Kaiser; Christoph Isbert; Christoph-Thomas Germer; Burkhard H A von Rahden
Journal:  Int J Colorectal Dis       Date:  2011-07-21       Impact factor: 2.571

Review 7.  Minimally invasive surgical treatment of sigmoid diverticulitis.

Authors:  B D Barry; J Leroy; D Mutter; H-S Wu; J Marescaux
Journal:  Langenbecks Arch Surg       Date:  2012-05-31       Impact factor: 3.445

8.  Is there anything we can modify among factors associated with morbidity following elective laparoscopic sigmoidectomy for diverticulitis?

Authors:  Jorge Silva-Velazco; Luca Stocchi; Meagan Costedio; Emre Gorgun; Hermann Kessler; Feza H Remzi
Journal:  Surg Endosc       Date:  2015-11-05       Impact factor: 4.584

9.  Single-incision laparoscopic surgery for diverticulitis in overweight patients.

Authors:  Andreas D Rink; Boris Vestweber; Jasmina Hahn; Angelika Alfes; Claudia Paul; Karl-Heinz Vestweber
Journal:  Langenbecks Arch Surg       Date:  2015-08-18       Impact factor: 3.445

10.  Elective Colectomy for Diverticulitis in Transplant Patients: Is It Worth the Risk?

Authors:  Janet T Lee; Steve Skube; Genevieve B Melton; Mary R Kwaan; Christine C Jensen; Robert D Madoff; Wolfgang B Gaertner
Journal:  J Gastrointest Surg       Date:  2017-04-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.